Genus Delivers Record Half-Year Profits and Advances China JV and Gene-Edited Pig Strategy

The latest announcement is out from Genus plc ( (GB:GNS) ).

Genus reported record first-half profits for the six months to 31 December 2025, as adjusted operating profit jumped on strong performance at its porcine unit PIC, a milestone payment from Chinese partner Beijing Capital Agribusiness and ongoing cost and efficiency gains from its Value Acceleration Programme in bovine unit ABS. Revenue was flat at £335.6m but adjusted profit before tax rose 57%, adjusted EPS climbed 53%, free cash flow remained solid and leverage fell, prompting a higher interim dividend and underlining the benefits of royalty-led growth, lower input costs and disciplined cash generation.

Strategically, the group advanced its long-term positioning with the formation of a Chinese porcine joint venture that will deconsolidate PIC China and is expected to bring in about £100m in fiscal Q4, while Canada’s approval of its PRRS-resistant pig gene edit marked a key step toward commercialising this flagship innovation in North America. Management said second-half trading momentum remains positive and, after factoring in the PIC China deconsolidation and broadly neutral FX, full-year adjusted profit guidance is in line with market expectations, reinforcing confidence in the company’s growth trajectory despite softer ABS revenue and ongoing regulatory and trade challenges in China.

The most recent analyst rating on (GB:GNS) stock is a Hold with a £3455.00 price target. To see the full list of analyst forecasts on Genus plc stock, see the GB:GNS Stock Forecast page.

Spark’s Take on GB:GNS Stock

According to Spark, TipRanks’ AI Analyst, GB:GNS is a Neutral.

Genus plc’s overall stock score is driven by strong corporate events and solid financial performance. However, technical indicators suggest caution due to potential overbought conditions, and the high P/E ratio indicates possible overvaluation.

To see Spark’s full report on GB:GNS stock, click here.

More about Genus plc

Genus is a UK-based animal genetics company that applies biotechnology to improve livestock breeding for dairy, beef and pork producers worldwide. Operating under the ABS and PIC brands in more than 75 countries, it supplies semen, embryos and breeding animals with proprietary genetics designed to boost production efficiency and quality across global meat and dairy supply chains.

Average Trading Volume: 170,257

Technical Sentiment Signal: Buy

Current Market Cap: £2.1B

Learn more about GNS stock on TipRanks’ Stock Analysis page.